Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel Prep Optimization for Colon Capsule Endoscopy
NCT05726097Phase 3Completed
- Sponsor
- Region Skåne
- Start
- Feb 2023
- Primary completion
- Oct 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of prucalopride, polyethylene glycol plus ascorbate in colon cancer, inflammatory bowel disease (IBD), Gastrointestinal Bleeding (GIB), colonic polyp, sponsored by Region Skåne. Started Feb 2023; status: completed.
02
Drugs
prucalopridepolyethylene glycol plus ascorbate
03
Conditions
colon cancerinflammatory bowel disease (IBD)Gastrointestinal Bleeding (GIB)colonic polyp
Beyond the preview
Go deeper on NCT05726097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726097.